fMRI and Opioid Abstinence

Eligibility Criteria

• * recent initiation of methadone or buprenorphine at APT Foundation within the past 6 months (i.e., period of time during which treatment drop-out and risk for relapse is highest);
• * eligibility for MRI scanning;
• * ability to commit to study visits.
• * current acute psychosis, mania, or suicidal ideation with intent, as assessed during screening with the SCID-5;
• * current intoxication or acute withdrawal at time of study visit sufficient to prevent participation based on: behavioral observation, breathalyzer, and SOWS assessment;
• * severe cognitive impairment as determined via trained clinical research staff through consent process and during consent quiz or as indicated by a PROMIS Cognitive Function tscore \<30 (i.e., severe impairment)
• * past or present history of intellectual disability, developmental disorder, or neurological disease;
• * head trauma with loss of consciousness \>30 min;
• * organ dysfunction or any unstable or untreated medical conditions that may interfere with study participation.